Concepedia

C. Cerveny

CC

Statistics

Publications

2

Citations

67

H-Index

2

Active since

2009

Affiliations

Alexion Pharmaceuticals (United States)(Current)

C. Cerveny is an author at Alexion Pharmaceuticals (United States) specializing in medicine, rituximab-based therapy, and pharmacology.

Publications per year

2009–2009

2

Publications

2

CD20-Directed Small Modular Immunopharmaceutical, TRU-015, Depletes Normal and Malignant B Cells

Martha Hayden-Ledbetter, C. Cerveny, Erik Espling et al. · Clinical Cancer Research · 2009 · 46 citations · Full text

, , +14

Evaluation of the effect of TRU-016, an anti-CD37 directed SMIP in combination with other therapeutic drugs in models of non-Hodgkin's lymphoma

Peter Baum, C. Cerveny, Brian Gordon et al. · Journal of Clinical Oncology · 2009 · 21 citations

, , +13

1–2 of 2